Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxRestructuring CostsRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateWages, Salaries and Other
Others
Ratios

Marimed (MRMD) Gross Profit (2016 - 2025)

Marimed (MRMD) has disclosed Gross Profit for 15 consecutive years, with $16.2 million as the latest value for Q3 2025.

  • On a quarterly basis, Gross Profit fell 3.41% to $16.2 million in Q3 2025 year-over-year; TTM through Sep 2025 was $60.1 million, a 10.95% decrease, with the full-year FY2024 number at $62.9 million, down 4.63% from a year prior.
  • Gross Profit was $16.2 million for Q3 2025 at Marimed, up from $16.0 million in the prior quarter.
  • In the past five years, Gross Profit ranged from a high of $19.4 million in Q2 2021 to a low of $12.7 million in Q4 2024.
  • A 5-year average of $16.1 million and a median of $16.2 million in 2025 define the central range for Gross Profit.
  • Peak YoY movement for Gross Profit: surged 215.13% in 2021, then fell 26.61% in 2024.
  • Marimed's Gross Profit stood at $15.5 million in 2021, then increased by 2.08% to $15.8 million in 2022, then increased by 9.52% to $17.3 million in 2023, then fell by 26.61% to $12.7 million in 2024, then rose by 27.54% to $16.2 million in 2025.
  • Per Business Quant, the three most recent readings for MRMD's Gross Profit are $16.2 million (Q3 2025), $16.0 million (Q2 2025), and $15.1 million (Q1 2025).